GenePOC Inc - Product Pipeline Analysis, 2017 Update

Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The companys POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, hospital acquired infections, sexually transmitted diseases and womens health. GenePOC is headquartered in Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GenePOC Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
GenePOC Inc Company Overview 5
GenePOC Inc Company Snapshot 5
GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview 5
GenePOC Inc Pipeline Analysis Overview 8
GenePOC Inc - Key Facts 8
GenePOC Inc - Major Products and Services 9
GenePOC Inc Pipeline Products by Development Stage 10
GenePOC Inc Pipeline Products Overview 13
GenePOC System - Bacillus atrophaeus subsp. globigii Assay 13
GenePOC System - Bacillus atrophaeus subsp. globigii Assay Product Overview 13
GenePOC System - Bacillus subtilis Assay 14
GenePOC System - Bacillus subtilis Assay Product Overview 14
GenePOC System - Campylobacter jejuni Assay 15
GenePOC System - Campylobacter jejuni Assay Product Overview 15
GenePOC System - Candida albicans Assay 16
GenePOC System - Candida albicans Assay Product Overview 16
GenePOC System - Enterococcus faecalis Assay 17
GenePOC System - Enterococcus faecalis Assay Product Overview 17
GenePOC System - Escherichia coli Assay 18
GenePOC System - Escherichia coli Assay Product Overview 18
GenePOC System - Influenza A Assay 19
GenePOC System - Influenza A Assay Product Overview 19
GenePOC System - Neonatal Infections Assay 20
GenePOC System - Neonatal Infections Assay Product Overview 20
GenePOC System - Respiratory Tract Infections Assay 21
GenePOC System - Respiratory Tract Infections Assay Product Overview 21
GenePOC System - Salmonella enterica Assay 22
GenePOC System - Salmonella enterica Assay Product Overview 22
GenePOC System - Sexually Transmitted Infections Assay 23
GenePOC System - Sexually Transmitted Infections Assay Product Overview 23
GenePOC System - Staphylococcus Assay 24
GenePOC System - Staphylococcus Assay Product Overview 24
GenePOC System - Streptococcus agalactiae Assay 25
GenePOC System - Streptococcus agalactiae Assay Product Overview 25
revogene 26
revogene Product Overview 26
revogene - Clostridium difficile Assay 27
revogene - Clostridium difficile Assay Product Overview 27
revogene - Group B Streptococcus Assay 28
revogene - Group B Streptococcus Assay Product Overview 28
GenePOC Inc - Key Competitors 29
GenePOC Inc - Key Employees 30
GenePOC Inc - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
GenePOC Inc, Recent Developments 32
Feb 02, 2017: GenePOC Announces GenePOC GBS Assay Launch in Europe and Middle East 32
Feb 02, 2017: GenePOC announces launch of CE-IVD marked test GenePOC CDiff in Europe and Middle East 32
Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument 33
Jan 11, 2017: GenePOC Announces CE Marking for its Second Bacteriological Test, GenePOC CDiff 33
Nov 03, 2016: GenePOC Announces Setup of an Extensive Network of Commercial Partners Across Europe for Distribution 33
Aug 30, 2016: Debiopharm Invests Double Digit Millions in the Canadian startup GenePOC, Specialized in the Development of Rapid Diagnostic Tests 33
Mar 10, 2016: Genepoc Proud To Announce $5.7 Million GAPP Partnership To Support Development And Commercialization Of Two New Tests On Its POC Platform 34
Feb 02, 2016: GenePOC obtains ISO 13485:2003 certification 34
Nov 18, 2015: Canadas genepoc expanding to enter lab and poc mdx market next year-2015 35
Nov 18, 2015: Canadas GenePOC Expanding to Enter Lab and POC MDx Market Next Year 36
Appendix 38
Methodology 38
About GlobalData 40
Contact Us 40
Disclaimer 40

List Of Tables


GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview 5
GenePOC Inc Pipeline Products by Equipment Type 6
GenePOC Inc Pipeline Products by Indication 7
GenePOC Inc, Key Facts 8
GenePOC Inc, Major Products and Services 9
GenePOC Inc Number of Pipeline Products by Development Stage 10
GenePOC Inc Pipeline Products Summary by Development Stage 11
GenePOC System - Bacillus atrophaeus subsp. globigii Assay - Product Status 13
GenePOC System - Bacillus atrophaeus subsp. globigii Assay - Product Description 13
GenePOC System - Bacillus subtilis Assay - Product Status 14
GenePOC System - Bacillus subtilis Assay - Product Description 14
GenePOC System - Campylobacter jejuni Assay - Product Status 15
GenePOC System - Campylobacter jejuni Assay - Product Description 15
GenePOC System - Candida albicans Assay - Product Status 16
GenePOC System - Candida albicans Assay - Product Description 16
GenePOC System - Enterococcus faecalis Assay - Product Status 17
GenePOC System - Enterococcus faecalis Assay - Product Description 17
GenePOC System - Escherichia coli Assay - Product Status 18
GenePOC System - Escherichia coli Assay - Product Description 18
GenePOC System - Influenza A Assay - Product Status 19
GenePOC System - Influenza A Assay - Product Description 19
GenePOC System - Neonatal Infections Assay - Product Status 20
GenePOC System - Neonatal Infections Assay - Product Description 20
GenePOC System - Respiratory Tract Infections Assay - Product Status 21
GenePOC System - Respiratory Tract Infections Assay - Product Description 21
GenePOC System - Salmonella enterica Assay - Product Status 22
GenePOC System - Salmonella enterica Assay - Product Description 22
GenePOC System - Sexually Transmitted Infections Assay - Product Status 23
GenePOC System - Sexually Transmitted Infections Assay - Product Description 23
GenePOC System - Staphylococcus Assay - Product Status 24
GenePOC System - Staphylococcus Assay - Product Description 24
GenePOC System - Streptococcus agalactiae Assay - Product Status 25
GenePOC System - Streptococcus agalactiae Assay - Product Description 25
revogene - Product Status 26
revogene - Product Description 26
revogene - Clostridium difficile Assay - Product Status 27
revogene - Clostridium difficile Assay - Product Description 27
revogene - Group B Streptococcus Assay - Product Status 28
revogene - Group B Streptococcus Assay - Product Description 28
GenePOC Inc, Key Employees 30
GenePOC Inc, Other Locations 31
Glossary 39

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

GenePOC Inc - Product Pipeline Analysis, 2020 Update

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving

USD 750 View Report

GenePOC Inc - Product Pipeline Analysis, 2019 Update

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving

USD 750 View Report

Binx Health Inc - Product Pipeline Analysis, 2021 Update

Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its

USD 750 View Report

Profound Medical Inc - Product Pipeline Analysis, 2021 Update

Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available